GOSS
$9.13
Gossamer Bio
$.17
1.90%
GOSS
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.80)
Revenue:  $0.00 Mil
Tuesday
Feb 9
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when GOSS reports earnings?
Beat
Meet
Miss

Where is GOSS's stock price going from here?
Up
Flat
Down
Stock chart of GOSS
Analysts
Summary of analysts' recommendations for GOSS
Score
Grade
Pivots
Resistance
$9.51
$9.33
$9.15

$8.97

Support
$8.79
$8.61
$8.43
Tweet
Growth
Description
Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio Inc. is based in San Diego, California.